We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over MIRT

MIRT - Molecular Imaging en radionuclidentherapie

Molecular Imaging and Radionuclide Therapy (formerly Turkish Journal of Nuclear Medicine) is the official publication of Turkish Society of Nuclear Medicine.

Focus and Scope

Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is a double-blind peer-review journal published in English language. It publishes original research articles, reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology. MIRT is published three times a year (February, June, October). Audience: Nuclear medicine physicians, medical physicists, radiopharmaceutical scientists, radiobiologists.

The editorial policies are based on the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations)” by the International Committee of Medical Journal Editors (2016, archived at http://www.icmje.org/) rules.

Molecular Imaging and Radionuclide Therapy is indexed in Pubmed, Pubmed Central (PMC), Emerging Sources Citation Index (ESCI), TUBITAK-ULAKBIM, Scopus, Gale/Cengage Learning, EBSCO databases, ProQuest Health & Medical Complete, CINAHL, DOAJ, British Library, Türkiye Atıf Dizini (Türkiye Citation Index), Turk Medline.

Wat is er nieuw in de nieuwste versie 1.0

Last updated on Aug 3, 2016

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van MIRT 1.0

Geüpload door

Max Max

Android vereist

Android 4.0.3+

Meer Info

MIRT Screenshots

Talen
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.